DMP-1-mediated Ghr gene recombination compromises skeletal development and impairs skeletal response to intermittent PTH

FASEB Journal

Volumn 30, Issue 2, 2016, Pages 635-652

  Liu, Zhongbo ^a   Kennedy, Oran D ^b,d   Cardoso, Luis ^b,d   Basta Pljakic, Jelena ^b,d   Partridge, Nicola C ^a   Schaffler, Mitchell B ^b,d   Rosen, Clifford J ^c   Yakar, Shoshana ^a  

^a NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^b City College of New York   (United States)

^c Maine Medical Center Research Institute   (United States)

^d NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

Fibroblast growth factor 23; Growth hormone receptor; Microcomputed tomography; Osteocyte; Parathyroid hormone

Indexed keywords

DENTIN MATRIX PROTEIN 1; GROWTH HORMONE; JANUS KINASE 2; PARATHYROID HORMONE; PHOSPHATE; SOMATOMEDIN C; CARRIER PROTEIN; DMP1 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; PHOSPHORUS; SCLEROPROTEIN; SOMATOTROPIN-BINDING PROTEIN;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE; BONE CELL; BONE DEVELOPMENT; BONE GROWTH; BONE MINERALIZATION; BONE STRENGTH; CONTROLLED STUDY; DENTIN; FEMALE; GENE; GENETIC RECOMBINATION; GHR GENE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCYTE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RADIUS; ANIMAL; BLOOD; BONE DENSITY; C57BL MOUSE; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE DENSITY; BONE DEVELOPMENT; CARRIER PROTEINS; CELL LINE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PARATHYROID HORMONE; PHOSPHORUS;

EID: 84958767726     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.15-275859     Document Type: Article

References (70)

1. Harvey, N., Dennison, E., and Cooper, C. (2010) Osteoporosis: impact on health and economics. Nat. Rev. Rheumatol. 6, 99-105
2. Baron, R., and Hesse, E. (2012) Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. J. Clin. Endocrinol. Metab. 97, 311-325
3. Khosla, S. (2013) Pathogenesis of age-related bone loss in humans. J. Gerontol. A Biol. Sci. Med. Sci. 68, 1226-1235
4. Erlandson, M. C., Kontulainen, S. A., Chilibeck, P. D., Arnold, C. M., Faulkner, R. A., and Baxter-Jones, A. D. (2012) Former premenarcheal gymnasts exhibit site-specific skeletal benefits in adulthood after long-term retirement. J. Bone Miner. Res. 27, 2298-2305
5. Ferrari, S., Rizzoli, R., Slosman, D., and Bonjour, J. P. (1998) Familial resemblance for bone mineral mass is expressed before puberty. J. Clin. Endocrinol. Metab. 83, 358-361
6. Cooper, C., Cawley, M., Bhalla, A., Egger, P., Ring, F., Morton, L., and Barker, D. (1995) Childhood growth, physical activity, and peak bone mass in women. J. Bone Miner. Res. 10, 940-947
7. Dennison, E. M., Syddall, H. E., Rodriguez, S., Voropanov, A., Day, I.N., and Cooper, C.; Southampton Genetic Epidemiology Research Group. (2004) Polymorphism in the growth hormone gene, weight in infancy, and adult bonemass. J. Clin. Endocrinol. Metab. 89, 4898-4903
8. Tahimic, C. G., Wang, Y., and Bikle, D. D. (2013) Anabolic effects of IGF-1 signaling on the skeleton. Front. Endocrinol. (Lausanne) 4, 6
9. Bonewald, L. F. (2011) The amazing osteocyte. J. BoneMiner. Res. 26, 229-238
10. Lanske, B., Karaplis, A. C., Lee, K., Luz, A., Vortkamp, A., Pirro, A., Karperien, M., Defize, L. H., Ho, C., Mulligan, R. C., Abou-Samra, A.B., Jüppner, H., Segre, G.V., and Kronenberg, H.M. (1996)PTH/ PTHrP receptor in early development and Indian hedgehogregulated bone growth. Science 273, 663-666
11. Miao, D., He, B., Karaplis, A. C., and Goltzman, D. (2002) Parathyroid hormone is essential for normal fetal bone formation. J. Clin. Invest. 109, 1173-1182
12. Xue, Y., Karaplis, A. C., Hendy, G. N., Goltzman, D., and Miao, D. (2005) Genetic models show that parathyroid hormone and 1, 25- dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Hum. Mol. Genet. 14, 1515-1528
13. Powell, W. F., Jr., Barry, K. J., Tulum, I., Kobayashi, T., Harris, S. E., Bringhurst, F. R., and Pajevic, P. D. (2011) Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J. Endocrinol. 209, 21-32
14. Saini, V., Marengi, D.A., Barry, K. J., Fulzele, K. S., Heiden, E., Liu, X., Dedic, C., Maeda, A., Lotinun, S., Baron, R., and Pajevic, P.D.(2013) Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. J. Biol. Chem. 288, 20122-20134
15. Pfeilschifter, J., Laukhuf, F., Müller-Beckmann, B., Blum, W. F., Pfister, T., and Ziegler, R. (1995) Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. J. Clin. Invest. 96, 767-774
16. Watson, P., Lazowski, D., Han, V., Fraher, L., Steer, B., and Hodsman, A. (1995) Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. Bone 16, 357-365
17. Wang, Y., Nishida, S., Boudignon, B.M., Burghardt, A., Elalieh, H. Z., Hamilton, M. M., Majumdar, S., Halloran, B. P., Clemens, T. L., and Bikle, D.D. (2007) IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone. J. Bone Miner. Res. 22, 1329-1337
18. Bikle, D. D., Sakata, T., Leary, C., Elalieh, H., Ginzinger, D., Rosen, C. J., Beamer, W., Majumdar, S., and Halloran, B. P. (2002) Insulinlike growth factor I is required for the anabolic actions ofparathyroid hormone on mouse bone. J. Bone Miner. Res. 17, 1570-1578
19. Miyakoshi, N., Kasukawa, Y., Linkhart, T. A., Baylink, D. J., and Mohan, S. (2001) Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology 142, 4349-4356
20. Yakar, S., Rosen, C. J., Beamer, W. G., Ackert-Bicknell, C. L., Wu, Y., Liu, J.L., Ooi, G.T., Setser, J., Frystyk, J., Boisclair, Y. R., and LeRoith, D. (2002) Circulating levels of IGF-1 directly regulate bone growth and density. J. Clin. Invest. 110, 771-781
21. Yakar, S., Rosen, C. J., Bouxsein, M. L., Sun, H., Mejia, W., Kawashima, Y., Wu, Y., Emerton, K., Williams, V., Jepsen, K., Schaffler, M. B., Majeska, R. J., Gavrilova, O., Gutierrez, M., Hwang, D., Pennisi, P., Frystyk, J., Boisclair, Y., Pintar, J., Jasper, H., Domene, H., Cohen, P., Clemmons, D., and LeRoith, D. (2009) Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism. FASEB J. 23, 709-719
22. Woo, S. M., Rosser, J., Dusevich, V., Kalajzic, I., and Bonewald, L. F. (2011) Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo. J. Bone Miner. Res. 26, 2634-2646
23. Bouxsein, M. L., Boyd, S. K., Christiansen, B. A., Guldberg, R. E., Jepsen, K. J., andMüller, R. (2010)Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone Miner. Res. 25, 1468-1486
24. Dempster, D. W., Compston, J. E., Drezner, M. K., Glorieux, F. H., Kanis, J.A., Malluche, H., Meunier, P. J., Ott, S.M., Recker, R. R., and Parfitt, A.M. (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 28, 2-17
25. Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-Hora, M., Feng, J. Q., Bonewald, L. F., Kodama, T., Wutz, A., Wagner, E. F., Penninger, J.M., and Takayanagi, H. (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 17, 1231-1234
26. Xiao, Z., Dallas, M., Qiu, N., Nicolella, D., Cao, L., Johnson, M., Bonewald, L., and Quarles, L. D. (2011) Conditional deletion of Pkd1 in osteocytes disrupts skeletalmechanosensing inmice. FASEB J. 25, 2418-2432
27. Kramer, I., Halleux, C., Keller, H., Pegurri, M., Gooi, J. H., Weber, P. B., Feng, J. Q., Bonewald, L. F., and Kneissel, M. (2010)Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Mol. Cell. Biol. 30, 3071-3085
28. Vijayakumar, A., Wu, Y., Sun, H., Li, X., Jeddy, Z., Liu, C., Schwartz, G. J., Yakar, S., and LeRoith, D. (2012) Targeted loss of GHR signaling in mouse skeletal muscle protects against high-fat dietinduced metabolic deterioration. Diabetes 61, 94-103
29. Wu, Y., Liu, C., Sun, H., Vijayakumar, A., Giglou, P. R., Qiao, R., Oppenheimer, J., Yakar, S., and LeRoith, D. (2011) Growth hormone receptor regulates b cell hyperplasia and glucosestimulated insulin secretion in obese mice. J. Clin. Invest. 121, 2422-2426
30. Vijayakumar, A., Buffin, N. J., Gallagher, E. J., Blank, J., Wu, Y., Yakar, S., and LeRoith, D. (2013)Deletion of growth hormone receptors in postnatal skeletal muscle of male mice does not alter muscle mass and response to pathological injury. Endocrinology 154, 3776-3783
31. Vijayakumar, A., Wu, Y., Buffin, N. J., Li, X., Sun, H., Gordon, R. E., Yakar, S., and LeRoith, D. (2012) Skeletal muscle growth hormone receptor signaling regulates basal, but not fasting-induced, lipid oxidation. PLoS One 7, e44777
32. Sheng, M.H., Lau, K.H., and Baylink, D. J. (2014) Role of osteocytederived insulin-like growth factor I in developmental growth, modeling, remodeling, and regeneration of the bone. J. Bone Metab. 21, 41-54
33. Sheng, M. H., Zhou, X. D., Bonewald, L. F., Baylink, D. J., and Lau, K. H. (2013) Disruption of the insulin-like growth factor-1 gene in osteocytes impairs developmental bone growth in mice. Bone 52, 133-144
34. Lavi-Moshayoff, V., Wasserman, G., Meir, T., Silver, J., and Naveh-Many, T. (2010) PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am. J. Physiol. Renal Physiol. 299, F882-F889
35. Kawata, T., Imanishi, Y., Kobayashi, K., Miki, T., Arnold, A., Inaba, M., and Nishizawa, Y. (2007) Parathyroid hormone regulates fibroblast growth factor-23 in amousemodel of primary hyperparathyroidism. J. Am. Soc. Nephrol. 18, 2683-2688
36. Ben-Dov, I. Z., Galitzer, H., Lavi-Moshayoff, V., Goetz, R., Kuro-o, M., Mohammadi, M., Sirkis, R., Naveh-Many, T., and Silver, J. (2007)The parathyroid is a target organ for FGF23 in rats. J. Clin. Invest. 117, 4003-4008
37. McCarthy, T.L., and Centrella, M. (2001)Local IGF-I expressionand bone formation. Growth Horm. IGF Res. 11, 213-219
38. Zhang, M., Xuan, S., Bouxsein, M. L., von Stechow, D., Akeno, N., Faugere, M. C., Malluche, H., Zhao, G., Rosen, C. J., Efstratiadis, A., and Clemens, T. L. (2002) Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J. Biol. Chem. 277, 44005-44012
39. DiGirolamo, D. J., Mukherjee, A., Fulzele, K., Gan, Y., Cao, X., Frank, S. J., and Clemens, T. L. (2007) Mode of growth hormone action in osteoblasts. J. Biol. Chem. 282, 31666-31674
40. Xian, L., Wu, X., Pang, L., Lou, M., Rosen, C. J., Qiu, T., Crane, J., Frassica, F., Zhang, L., Rodriguez, J. P., Jia, X., Yakar, S., Xuan, S., Efstratiadis, A., Wan, M., and Cao, X. (2012)Matrix IGF-1maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat. Med. 18, 1095-1101
41. Elis, S., Courtland, H. W., Wu, Y., Fritton, J. C., Sun, H., Rosen, C. J., and Yakar, S. (2010) Elevated serum IGF-1 levels synergize PTH action on the skeleton only when the tissue IGF-1 axis is intact. J. Bone Miner. Res. 25, 2051-2058
42. Elis, S., Courtland, H. W., Wu, Y., Rosen, C. J., Sun, H., Jepsen, K. J., Majeska, R. J., and Yakar, S. (2010) Elevated serumlevels of IGF-1 are sufficient to establish normal body size and skeletal properties even in the absence of tissue IGF-1. J. Bone Miner. Res. 25, 1257-1266
43. Lau, K.H., Baylink, D. J., Zhou, X.D., Rodriguez, D., Bonewald, L. F., Li, Z., Ruffoni, D., Müller, R., Kesavan, C., and Sheng, M.H. (2013) Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity. Am. J. Physiol. Endocrinol. Metab. 305, E271-E281
44. Zhao, G., Monier-Faugere, M. C., Langub, M. C., Geng, Z., Nakayama, T., Pike, J. W., Chernausek, S. D., Rosen, C. J., Donahue, L. R., Malluche, H. H., Fagin, J. A., and Clemens, T. L. (2000) Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141, 2674-2682
45. Brennan-Speranza, T. C., Rizzoli, R., Kream, B. E., Rosen, C., and Ammann, P. (2011) Selective osteoblast overexpression of IGF-I in mice prevents low protein-induced deterioration of bone strength and material level properties. Bone 49, 1073-1079
46. Shah, R., Licata, A., Oyesiku, N. M., and Ioachimescu, A. G. (2012) Acromegaly as a cause of 1, 25-dihydroxyvitamin D-dependent hypercalcemia: case reports and review of the literature. Pituitary 15 (Suppl 1), S17-S22
47. Ahmad, A. M., Thomas, J., Clewes, A., Hopkins, M. T., Guzder, R., Ibrahim, H., Durham, B. H., Vora, J. P., and Fraser, W. D. (2003) Effects of growth hormone replacement on parathyroid hormone sensitivity andbone mineralmetabolism. J. Clin. Endocrinol.Metab. 88, 2860-2868
48. Joseph, F., Ahmad, A. M., Ul-Haq, M., Durham, B.H., Whittingham, P., Fraser, W. D., and Vora, J. P. (2008) Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis. J. Bone Miner. Res. 23, 721-729
49. Kasukawa, Y., Baylink, D. J., Wergedal, J. E., Amaar, Y., Srivastava, A. K., Guo, R., and Mohan, S. (2003) Lack of insulin-like growth factor I exaggerates the effect of calcium deficiency on bone accretion in mice. Endocrinology 144, 4682-4689
50. Warden, S. J., Hill, K. M., Ferira, A. J., Laing, E. M., Martin, B. R., Hausman, D.B., Weaver, C.M., Peacock, M., and Lewis, R.D. (2013) Racial differences in cortical bone and their relationship to biochemical variables in black and white children in the early stages of puberty. Osteoporos. Int. 24, 1869-1879
51. Tylavsky, F.A., Ryder, K.M., Li, R., Park, V., Womack, C., Norwood, J., Carbone, L. D., and Cheng, S. (2007) Preliminary findings: 25(OH) D levels and PTH are indicators of rapid bone accrual in pubertal children. J. Am. Coll. Nutr. 26, 462-470
52. Kostenuik, P. J., Harris, J., Halloran, B. P., Turner, R. T., Morey-Holton, E. R., and Bikle, D. D. (1999) Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I. J. Bone Miner. Res. 14, 21-31
53. Nishida, S., Yamaguchi, A., Tanizawa, T., Endo, N., Mashiba, T., Uchiyama, Y., Suda, T., Yoshiki, S., and Takahashi, H. E. (1994) Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. Bone 15, 717-723
54. Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P., Parfitt, A. M., and Manolagas, S. C. (1999) Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J. Clin. Invest. 104, 439-446
55. Guevarra, M. S., Yeh, J. K., CastroMagana, M., and Aloia, J. F. (2010) Synergistic effect of parathyroid hormone and growth hormone on trabecular and cortical bone formation in hypophysectomized rats. Horm. Res. Paediatr. 73, 248-257
56. Mosekilde, L., Tornvig, L., Thomsen, J. S., Orhii, P. B., Banu, M. J., and Kalu, D. N. (2000) Parathyroid hormone and growth hormone have additive or synergetic effect when used as intervention treatment in ovariectomized rats with established osteopenia. Bone 26, 643-651
57. Silvestrini, G., Ballanti, P., Leopizzi, M., Sebastiani, M., Berni, S., Di Vito, M., and Bonucci, E. (2007) Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone. J. Mol. Histol. 38, 261-269
58. Bellido, T., Ali, A. A., Gubrij, I., Plotkin, L. I., Fu, Q., OBrien, C. A., Manolagas, S. C., and Jilka, R. L. (2005) Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology 146, 4577-4583
59. Keller, H., and Kneissel, M. (2005) SOST is a target gene for PTH in bone. Bone 37, 148-158
60. Gooi, J.H., Pompolo, S., Karsdal, M. A., Kulkarni, N. H., Kalajzic, I., McAhren, S. H., Han, B., Onyia, J. E., Ho, P. W., Gillespie, M. T., Walsh, N. C., Chia, L. Y., Quinn, J.M., Martin, T. J., and Sims, N. A. (2010) Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes. Bone 46, 1486-1497
61. Kramer, I., Loots, G. G., Studer, A., Keller, H., and Kneissel, M. (2010) Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice. J. Bone Miner. Res. 25, 178-189
62. Drake, M.T., Srinivasan, B., Modder, U. I., Peterson, J.M., McCready, L.K., Riggs, B. L., Dwyer, D., Stolina, M., Kostenuik, P., and Khosla, S. (2010) Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J. Clin. Endocrinol.Metab. 95, 5056-5062
63. Qin, L., Qiu, P., Wang, L., Li, X., Swarthout, J. T., Soteropoulos, P., Tolias, P., and Partridge, N. C. (2003) Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. J. Biol. Chem. 278, 19723-19731
64. Kravchenko, I. V., Furalyov, V. A., and Popov, V. O. (2012) Stimulation of mechano-growth factor expression by myofibrillar proteins in murine myoblasts and myotubes. Mol. Cell. Biochem. 363, 347-355
65. Kravchenko, I. V., Furalyov, V. A., Lisitsina, E. S., and Popov, V. O. (2011) Stimulation of mechano-growth factor expression by second messengers. Arch. Biochem. Biophys. 507, 323-331
66. Gan, Y., Paterson, A. J., Zhang, Y., Jiang, J., and Frank, S. J. (2014) Functional collaboration of insulin-like growth factor-1 receptor (IGF-1R), but not insulin receptor (IR), with acute GH signaling in mouse calvarial cells. Endocrinology 155, 1000-1009
67. Gan, Y., Zhang, Y., Buckels, A., Paterson, A. J., Jiang, J., Clemens, T.L., Zhang, Z. Y., Du, K., Chang, Y., and Frank, S. J. (2013) IGF-1R modulation of acute GH-induced STAT5 signaling: role of protein tyrosine phosphatase activity. Mol. Endocrinol. 27, 1969-1979
68. Ma, F., Wei, Z., Shi, C., Gan, Y., Lu, J., Frank, S. J., Balducci, J., and Huang, Y. (2011) Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet b-cells. Mol. Endocrinol. 25, 2119-2133
69. Gan, Y., Zhang, Y., Digirolamo, D. J., Jiang, J., Wang, X., Cao, X., Zinn, K.R., Carbone, D. P., Clemens, T. L., and Frank, S. J. (2010)Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GHinduced STAT5 signaling. Mol. Endocrinol. 24, 644-656
70. Huang, Y., Kim, S. O., Yang, N., Jiang, J., and Frank, S. J. (2004) Physical and functional interaction of growth hormone and insulinlike growth factor-I signaling elements. Mol. Endocrinol. 18, 1471-1485